Reply to: "Is NAFLD a key driver of brain dysfunction?"

Affiliations

¹ The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, UK. Electronic address: a.hadjichambi@researchinliver.org.uk.
² Inserm U1313, Université de Poitiers et CHU de Poitiers, Poitiers, France. Electronic address: luc.pellerin@univ-poitiers.fr.

Comment

Anna Hadjihambi et al. J Hepatol. 2023 Apr.

. 2023 Apr;78(4):e130-e131.

doi: 10.1016/j.jhep.2022.12.020. Epub 2022 Dec 31.

¹ The Roger Williams Institute of Hepatology London, Foundation for Liver Research, London, UK; Faculty of Life Sciences and Medicine, King's College London, UK. Electronic address: a.hadjichambi@researchinliver.org.uk.
² Inserm U1313, Université de Poitiers et CHU de Poitiers, Poitiers, France. Electronic address: luc.pellerin@univ-poitiers.fr.

No abstract available

Comment on

Partial MCT1 invalidation protects against diet-induced non-alcoholic fatty liver disease and the associated brain dysfunction.
Hadjihambi A, Konstantinou C, Klohs J, Monsorno K, Le Guennec A, Donnelly C, Cox IJ, Kusumbe A, Hosford PS, Soffientini U, Lecca S, Mameli M, Jalan R, Paolicelli RC, Pellerin L. Hadjihambi A, et al. J Hepatol. 2023 Jan;78(1):180-190. doi: 10.1016/j.jhep.2022.08.008. Epub 2022 Aug 19. J Hepatol. 2023. PMID: 35995127
Is NAFLD a key driver of brain dysfunction?
Sandforth L, El-Agroudy NN, Birkenfeld AL. Sandforth L, et al. J Hepatol. 2023 Apr;78(4):e129-e130. doi: 10.1016/j.jhep.2022.09.022. Epub 2022 Oct 7. J Hepatol. 2023. PMID: 36216136 No abstract available.